The lipid accumulation product (LAP) association with hyperuricemic hypertension in the China Health and Nutrition Survey: A cross-sectional study

Jing Wang,Yaping Geng,Mengyao Zhou,Xiangju Yin,Hao Wang,Zhiguang Ping,Yanna Shang
DOI: https://doi.org/10.6133/apjcn.202212_31(4).0011
2022-01-01
Asia Pacific Journal of Clinical Nutrition
Abstract:Background and Objectives: Previous studies have explored the relationship between lipid accumulation product (LAP) and hypertension or hyperuricemia. However, the association between LAP and hypertension with hyperuricemia (HWH) is inconclusive. Therefore, we aimed to evaluate the association between LAP and HWH. Methods and Study Design: A total of 7897 participants aged 18 to 75 years from the 2009 wave of the China Health and Nutrition Survey were included in this study. General linear regression models were built to assess the association of LAP with systolic blood pressure (SBP), diastolic blood pressure (DBP), and uric acid (UA) concentrations. Logistic regression models were used to estimate the association between LAP and HWH risk, restricted cubic splines (RCS) were used to analyze the dose-response relationship between them. Results: The prevalence of HWH was significantly higher in men (7.63%) than in women (1.99%) (chi(2)=142; p<0.001). After adjustment for potential confounders, LAP scores were positively correlated with SBP, DBP, and UA concentrations in both genders (all p-trend <0.01). Compared with participants in the lowest quartile of LAP, those in the highest quartile had a higher risk of HWH [OR (95% CI)=12.2 (7.22-20.5) for men, OR (95% CI)=14.5 (3.5060.2) for women]. The RCS results suggested a nonlinear relationship between the continuous change of LAP and HWH risk after adjustment for confounding factors in each gender (p for nonlinearity <0.001). Conclusions: Our findings suggest that higher LAP scores was strongly associated with greater HWH risk in Chinese adults.
What problem does this paper attempt to address?